The National Institute for Health and Care Excellence (NICE) has unveiled its final draft guidance on the rollout of tirzepatide, a weight loss medication set to benefit around 220,000 people living with obesity in England over the next three years.

The Association for the Study of Obesity (ASO) is delighted to announce a one-day MDT clinical meeting on Thursday, January 16, 2025, at the Crowne Plaza, Nottingham.

Women with polycystic ovary syndrome (PCOS) and obesity are more likely to give birth to smaller babies, according to a recent study by the Norwegian University of Science and Technology. Babies born to mothers with both conditions had lower birth weights, shorter lengths, and smaller head circumferences compared to children of mothers without these conditions.

Emerging research suggests that visceral fat, a type of fat stored around internal organs, may increase the risk of Alzheimer’s disease by contributing to brain inflammation and toxic protein accumulation. Findings were presented at the Radiological Society of North America Annual Meeting by researchers from the Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis.

A new study published in the Journal of Neurology, Neurosurgery & Psychiatry reveals that obesity and cardiovascular risks can accelerate brain aging more significantly and earlier in men compared to women.

An injectable weight-loss drug can reduce type 2 diabetes risk in people with obesity and prediabetes by roughly 90 per cent, a new study has indicated.

The Obesity & Weight Management Alliance is thrilled to reveal the expert speaker line-up for its 2025 national conference, a must attend event for healthcare professionals dedicated to tackling obesity.

Regularly drinking whole milk can help people lower their body weight, a new study has suggested.

A new study published in the British Journal of Sports Medicine challenges the prevailing focus on weight loss as the primary strategy for improving health outcomes.

The Obesity & Weight Management Alliance is calling on registered healthcare professionals to join its growing network and gain access to free educational resources, events, and updates on the latest best practices in obesity management.

Findings from new research published in Arthritis & Rheumatology has revealed that weight loss following treatment with anti-obesity medications is associated with a reduced risk of developing gout and experiencing recurrent gout flares among individuals living with overweight or obesity.

American Samoa has been named as the most obese nation around the world, new data has shown.

A recent clinical trial has shown promising results for setmelanotide, a medication designed to treat obesity caused by rare genetic disorders in children as young as two years old.

A recent study has revealed how socioeconomic disadvantage and genetic predisposition combine to influence obesity risk from early childhood through adolescence.

Recognising that men are less likely to participate in traditional weight-loss programmes, a new study published in The Lancet highlighted an innovative approach to change that - Hockey Fans in Training (Hockey FIT).

At the recent Obesity Week 2024 conference in America, new research revealed that people taking anti-obesity medications (AOMs), including popular GLP-1 drugs, appear to decrease their alcohol consumption.

Registrations are now open for a free webinar exploring how bias may influence the care and well-being of people living with obesity.

The Scottish Government and NHS Scotland have released a landmark consensus statement aimed at standardising the use of injectable weight management drugs across the country.

In a groundbreaking study, researchers have identified a critical link between the liver and brain that helps regulate our daily eating patterns, offering a promising new approach for managing obesity.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to healthcare professionals, urging vigilance for signs of misuse involving popular obesity injections like Wegovy. The advisory follows reports of individuals using these weight-loss drugs without medical need, leading to severe health complications.